Simvastatin Ist ein Cholesterin-Senker, der von diversen Generika-Herstellern produziert wird und eine Reduktion des Auftretens neuer Läsionen zur Folge haben soll. 20. 5. 2010; PubMed.gov; Simvastatin treatment in patients with RRMS receiving interferon beta 1a: a doubleblind randomized controlled trial http://www.ncbi.nlm.nih.gov/pubmed/20488825 8. 7. 2011; PubMed.gov; Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. http://www.ncbi.nlm.nih.gov/pubmed/21742556 „INTERPRETATION: We found no beneficial effect of simvastatin as add-on therapy to interferon beta-1a. Although unlikely, we can not exclude that combination of other statins with other disease-modifying drugs still could be beneficial.“ 15. 9. 2011; PubMed.gov; Simvastatin improves final visual outcome in acute optic neuritis: a randomized study. http://www.ncbi.nlm.nih.gov/pubmed/21921071 „Conclusion: This study provides Class I evidence that simvastatin 80 mg daily is well tolerated and possibly effective in patients with acute ON (optic neuritis).“ „Wer nicht zur Wahl geht, stärkt die, gegen die er protestieren will“ Zur Medikamenten-Übersicht